If you need explaining how early diagnosis (up to 7 years earlier, with a simple blood tests instead of multiple invasive procedures) can help a patient and doctor(s) provide a better outcome, it's best you don't buy in anyway.
You obviously don't know anyone living with Endo.
The main thing here is that we will have 3 tests bringing in revenue by halfway through 2025.
How much is completely unknown, thus the current SP. But based on market sizes and the game changing nature of the tests, we could be talking blue sky on steroids.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)